Development of ONCR-177, an miR-attenuated oncolytic HSV-1 designed to potently activate systemic antitumor immunity
Brian B. Haines,Agnieszka Denslow,Michael S. Ball,Jacqueline Gursha,Daniel Wambua,Cecilia Kwong,Lingxin Kong,Prajna Behera,Peter Grzesik,Caitlin Goshert,Allison Colthart,Jennifer S. Lee,Terry Farkaly,Edward M. Kennedy,Lorena Lerner,Christophe Queva CANCER RESEARCH（2019）
AI 理解论文
溯源树
样例
